Literature DB >> 1677134

The case against thiomersal.

D Seal, L Ficker, P Wright, V Andrews.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 1677134     DOI： 10.1016/0140-6736(91)90455-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Thimerosal compromises human dendritic cell maturation, IL-12 production, chemokine release, and T-helper polarization.

Authors:  Emily Loison; Marie-Lise Gougeon
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

2.  Control of microbial contamination in unpreserved eyedrops.

Authors:  G B Oldham; V Andrews
Journal:  Br J Ophthalmol       Date:  1996-07       Impact factor: 4.638

Review 3.  Integrating experimental (in vitro and in vivo) neurotoxicity studies of low-dose thimerosal relevant to vaccines.

Authors:  José G Dórea
Journal:  Neurochem Res       Date:  2011-02-25       Impact factor: 4.414
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.